• 1
    Shmulewitz D, Auerbach SB, Lehner T, et al. Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia. Hum Hered 2001;51:8-19.
  • 2
    Lowe JK, Maller JB, Pe'er I, et al. Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae. PLoS Genet 2009;5:e1000365.
  • 3
    Contois J, McNamara JR, Lammi-Keefe C, et al. Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 1996;42:507-514.
  • 4
    Donahue RP, Jacobs DR, Sidney S, et al. Distribution of lipoproteins and apolipoproteins in young adults The CARDIA Study. Arteriosclerosis 1989;9:656-664.
  • 5
    Brown SA, Hutchinson R, Morrisett J, et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993;13:1139-1158.
  • 6
    Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 2004;27:2444-2449.
  • 7
    Office FSoMNS. 2000 Census of the Federated States of Micronesia. 2000. Palikir, Pohnpei.
  • 8
    Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-2749.
  • 9
    Burrows NR, Geiss LS, Engelgau MM, et al. Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: an increasing burden. Diabetes Care 2000;23:1786-1790.
  • 10
    Tam WH, Ma RCW, Yang X, et al. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero. Pediatrics 2008;122:1229-1234.
  • 11
    Schumacher C, Ferucci ED, Lanier AP, et al. Metabolic syndrome: prevalence among American Indian and Alaska native people living in the southwestern United States and in Alaska. Metab Syndr Relat Disord 2008;6:267-273.
  • 12
    Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005;294:1773-1781.
  • 13
    North KE, Howard BV, Welty TK, et al. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am J Epidemiol 2003;157:303-314.
  • 14
    Lee CM, Huxley RR, Woodward M, et al. Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord 2008;6:37-46.
  • 15
    Sumner AE, Zhou J, Doumatey A, et al. Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in West Africans and African Americans with metabolic syndrome: implications for cardiovascular disease prevention. CVD Prev Control 2010;5:75-80.
  • 16
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
  • 17
    Mahley RW, Palaoglu KE, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995;36:839-859.
  • 18
    Hodoglugil U, Williamson DW, Huang Y, et al. Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks. Atherosclerosis 2005;183:199-212.
  • 19
    Hodoglugil U, Williamson DW, Mahley RW. Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population. J Lipid Res 2010;51:422-430.
  • 20
    Goldenberg I, Benderly M, Sidi R, et al. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Am J Cardiol 2009;41-45. Epub 2008 Oct 10.